Media
Latest News
WASHINGTON – Congressman Morgan Luttrell (R-TX) and his Republican colleagues on the House Armed Services Committee (HASC) sent a letter to Secretary of Defense Lloyd J. Austin III demanding an immediate response to the formal inquiry launched by HASC Chairman Mike Rogers (R-AL) on Secretary Austin’s disappearance and failure to ensure a “smooth transition from your day-to-day management and leadership of the Department by failing to initiate an obvious and immediate transfer of authority to your deputy and disclosure to relevant officials.”
WASHINGTON – Congressman Morgan Luttrell (R-TX) applauded the Department of Veterans Affairs’ decision to request applications for proposals to research the use of psychedelic therapies to treat post-traumatic stress disorder (PTSD), traumatic brain injuries (TBI), and other combat-related injuries.
President Joe Biden has officially signed a large-scale defense bill that contains provisions to fund clinical trials into the therapeutic potential of psychedelics for active duty military service members.
The president signed the 2024 National Defense Authorization Act (NDAA) into law on Friday, about a week after Congress approved the final deal and sent it to his desk.
WASHINGTON – Congressman Morgan Luttrell (R-TX), along with Congresswomen Mariannette Miller-Meeks (R-IA), Elissa Slotkin (D-MI), and Rob Menendez (D-NJ), introduced the Customs-Trade Partnership Against Terrorism (CTPAT) Pilot Program Act. This legislation would pilot expanding CTPAT to include “freight forwarders” and warehouses, helping reduce disruption of international trade, strengthen border security, and reduce supply chain congestion.
WASHINGTON — Tucked within Congress’ colossal annual defense bill is a priority a vocal group of Texas conservatives has long pushed: Using psychedelics to treat post-traumatic stress disorder.
WASHINGTON -- Congressman Morgan Luttrell (R-TX) scored several key wins in the Fiscal Year 2024 (FY24) National Defense Authorization Act (NDAA), which was adopted in the House and Senate and now heads to the President’s desk to be signed into law. As a member of the House Armed Services Committee and conferee to the NDAA Conference Committee, Rep. Luttrell was responsible for helping craft this legislation.
WASHINGTON — Sixty percent of veterans who die from suicide each year had no recent engagement with health care services at the Department of Veterans Affairs.
More so, many of the veterans who did reach out for help waited until they were at imminent risk of suicide, according to testimony at a hearing Tuesday held by the House Committee on Veterans’ Affairs health oversight subpanel.
Lawmakers frustrated with federal officials’ lack of progress in preventing veterans suicides suggested on Tuesday that more of the $16 billion allotted for those outreach efforts be given to outside community groups, saying that increased urgency is needed in addressing the problem
Congress is on track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics.
Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.
Bipartisan and bicameral congressional lawmakers have reached an agreement on a large-scale defense bill that contains a House GOP-led section to fund studies into the therapeutic use of psychedelics such as psilocybin and MDMA for military service members.